Clinical efficacy of buprenorphine to minimize distress in MRL/lpr mice.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European Journal of Pharmacology

• Publication date

  2007-07-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.EJPHAR.2007.03.048PMID 17490635PMCID PMC2570058
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferon regulatory factor‐1 gene deletion decreases glomerulonephritis in MRL/lpr mice

  2006cited by this paper
• Effects of μ-, δ- and κ-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice

  2006cited by this paper
• Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice.

  2006cited by this paper
• Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain.

  2005influential reference
• Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochloride.

  2005influential reference
• Interaction of μ‐opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice

  2005cited by this paper
• Buprenorphine Does Not Affect Acute Murine Toxoplasmosis and is Recommended as an Analgesic in Toxoplasma gondii Studies in Mice

  2005influential reference
• Buprenorphine Antinociception is Abolished, but Naloxone-Sensitive Reward is Retained, in μ-Opioid Receptor Knockout Mice

  2004cited by this paper
• High expression of interleukin‐1β in the corneal epithelium of MRL/lpr mice is under the control of their genetic background

  2004cited by this paper
• Behaviour-based assessment of the duration of laparotomy-induced abdominal pain and the analgesic effects of carprofen and buprenorphine in rats

  2004cited by this paper
• Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses

  2004cited by this paper
• Effect of genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production and renal disease in MRL/lpr mice.

  2003cited by this paper
• Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.

  2003influential reference
• Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system.

  2003cited by this paper
• No detrimental effect from chronic exposure to buprenorphine on corticosteroid-binding globulin and corticosensitive immune parameters.

  2003cited by this paper
• Critical anthropomorphic evaluation and treatment of postoperative pain in rats and mice.

  2003influential reference
• Involvement of central μ-opioid system in the scratching behavior in mice, and the suppression of it by the activation of κ-opioid system

  2003cited by this paper
• Buprenorphine Blocks ϵ- and μ-Opioid Receptor-Mediated Antinociception in the Mouse

  2003influential reference
• Buprenorphine: new pharmacological aspects.

  2003cited by this paper
• Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase.

  2002cited by this paper
• The Subpopulation of CD4+CD25+ Splenocytes That Delays Adoptive Transfer of Diabetes Expresses L-Selectin and High Levels of CCR71

  2002cited by this paper
• Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/Ipr mice

  2002cited by this paper
• Tolerance to the analgesic effect of buprenorphine, butorphanol, nalbuphine, and cyclorphan, and cross-tolerance to morphine

  2001influential reference
• Complement Component C3 Is Not Required for Full Expression of Immune Complex Glomerulonephritis in MRL/lpr Mice

  2001cited by this paper
• Inhibition of Mesangial Cell Nitric Oxide in MRL/lpr Mice by Prostaglandin J2 and Proliferator Activation Receptor-γ Agonists1

  2000cited by this paper
• Buprenorphine given after surgery does not alter renal ischemia/reperfusion injury.

  2000cited by this paper
• Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray.

  2000cited by this paper
• The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice.

  2000influential reference
• Body condition scoring: a rapid and accurate method for assessing health status in mice.

  1999cited by this paper
• Pharmacological characterization of buprenorphine, a mixed agonist–antagonist with κ3 analgesia

  1997cited by this paper
• Haematological changes in buprenorphine-treated mice.

  1997influential reference
• Analgesic efficacy of acetaminophen and buprenorphine administered in the drinking water of rats.

  1997influential reference
• Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia.

  1997cited by this paper
• Analgesics in mice used in cancer research: reduction of discomfort?

  1997influential reference
• CUTANEOUS MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS: STUDY FROM LAHORE, PAKISTAN

  1996cited by this paper
• Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

  1992cited by this paper
• Buprenorphine: bell-shaped dose-response curve for its antagonist effects.

  1991influential reference
• Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains

  1978cited by this paper

• Selective histone deacetlyase inhibition decreases disease in lupus-prone mice

  2016cites this paper
• Osteotomy models – the current status on pain scoring and management in small rodents

  2016cites this paper
• Guidelines for standard preclinical experiments in the mouse model of myasthenia gravis induced by acetylcholine receptor immunization.

  2015cites this paper
• Buprenorphine for pain relief in mice: repeated injections vs sustained-release depot formulation

  2015cites this paper
• Local cryoanalgesia is effective for tail-tip biopsy in mice.

  2013cites this paper
• The utility of fecal corticosterone metabolites and animal welfare assessment protocols as predictive parameters of tumor development and animal welfare in a murine xenograft model.

  2013cites this paper
• Safety and efficacy of buprenorphine for analgesia in laboratory mice and rats

  2012cites this paper
• Beneficial Effect of Bupleurum Polysaccharides on Autoimmune-Prone MRL-lpr Mice

  2012cites this paper
• Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles

  2009cites this paper